Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

Wim Laleman(University Hospital Münster), Frederik Nevens(KU Leuven), Alexander Wilmer(KU Leuven), Johan Fevery(KU Leuven), Pieter Evenepoel(KU Leuven), Marcel Zeegers(KU Leuven), Chris Verslype(Universitair Ziekenhuis Leuven), Zahur Zaman(KU Leuven), Ingrid Vander Elst(KU Leuven)
Critical Care
July 19, 2006
10.1186/cc4985
Cited by 249

Related Papers

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1k